Medical condition
Pneumonia
Pneumonia is a medical condition tracked by NovaPharmaNews across 12 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- telavancin (VIBATIV) Antiinfectives for systemic use (J01)
- meropenem (VABOREM) Antiinfectives for systemic use (J01)
- aztreonam (CAYSTON) Antiinfectives for systemic use (J01)
- telithromycin (KETEK) Antiinfectives for systemic use (J01)
- anakinra (KINERET) Antineoplastic and immunomodulating agents (L04)
- ceftaroline fosamil (ZINFORO) Antiinfectives for systemic use (J01)
- ceftazidime (ZAVICEFTA) Antiinfectives for systemic use (J01)
- remdesivir (VEKLURY) Antiinfectives for systemic use (J05)
- doripenem (DORIBAX) Antiinfectives for systemic use (J01)
- pneumococcal polysaccharide conjugate vaccine (adsorbed) (SYNFLORIX) Antiinfectives for systemic use (J07)
- cefepime (EXBLIFEP) Antiinfectives for systemic use (J01)
- ceftolozane (ZERBAXA) Antiinfectives for systemic use (J01)
Latest Pneumonia news
Pfizer's Next-Gen Pneumonia Shot Outperforms Prevnar 20
Pfizer's latest pneumonia vaccine shows superior efficacy compared to Prevnar 20, raising significant investment interest. This article explores the implications for pharma teams and investors.
FDA Approves Zithromax for Pediatric Community-Acquired Pneumonia
The FDA has officially approved Zithromax for the treatment of pediatric community-acquired pneumonia, providing a vital option for managing this common respiratory condition in children.